https://asahikaseiventures.com

Create the future, together | AsahiKasei Venturesinvestment, venture, material, healthcare, Menlo Park, Boston, JapanWe invest in Materials and Healthcare. Create the future, together.Create the future, together | AsahiKasei Ventures About us Portfolio Team Contact News We invest in  Materials, Homes and Healthcare. ∇ Portfolio All Energy/Material IoT/IIoT Food/Agri Frontier Digital Health Medical Device Pharma Services Therapeutics Construction/Real estate Aerobiotix is a pioneer in airborne infection control products that provide real-time, in room solutions for hospitals, ASCs, long term care and office based settings. Recognizing that healthcare doesn't stop at the patient, we drive novel technologies to optimize environments of care for patients and healthcare stakeholders. Aerobiotix's mission is to provide airborne infection control solutions leveraging peer-reviewed science and providing its customers both daily protection as well as robust monitoring data to further inform and assist their infection control programs. website AiCure uses artificial intelligence to see, hear and understand how people respond to treatment across clinical trials and patient care. website Allievex is a biopharmaceutical company developing therapeutics for rare pediatric neurological diseases.  The lead program is an intracerebroventricular enzyme replacement therapy to treat Sanfilippo syndrome type B. website AM Batteries is a leading player in lithium-ion dry-electrode technology. Our ‘powder to electrode’ method cuts the drying and solvent recovery steps, creating a more energy-efficient electrode manufacturing process. This is a revolutionary technology that will significantly reduce the amount of chemicals and the overall carbon footprint of the electrode manufacturing process. Completely eliminating the solvent usage and recovery as well as the entire drying process, greatly reduces capital equipment, energy consumption, and CO2 emissions in the battery industry. website The Aryballe digital nose relies on biosensors developed to mimic human olfaction. Digital olfaction made by Aryballe is a combination of biotech, nanosciences, IT and cognitive sciences. The company works on innovative topics with a variety of industries thanks to the versatility of their technology and the large range of odors detected. Market focus: Food and Beverages, Automotive, and Fragrances & Cosmetics website Avation Medical is developing patient-friendly systems that make the promise of neuromodulation more accessible to patients and their physicians. website Axine develops low cost, chemical - free solutions for treating ammonia and toxic organics in industrial wastewater addressing multi - billion pain points for customers in microelectronics, chemical, pharmaceutical and other industries. Axine solutions are based on a breakthrough electrochemical technology that is compact, modular and integrates into existing treatment plants to target specific pain points without disrupting operations. Their service model enables customers to access the technology with minimal capital investment. This enables them to immediately reduce costs and risks, eliminate off - site wastewater trucking and disposal, improve wastewater system performance, increase water reuse and ensure compliance. website Azafaros is developing a novel, breakthrough therapy for the treatment of devastating pediatric lysosomal storage disorders, including Niemann-Pick, GM gangliosidoses and other rare conditions. The company is in clinical trial. website CASTOR is an industry 4.0 startup in Israel, selling an automatic "BOM optimization" software to enable manufacturers to improve their supply chain resiliency, utilizing the benefits of Additive Manufacturing. It is a cloud-based and 'on-prem' software that analyses each part within existing product design of discrete manufacturing, and identifies parts that are a good fit for 3D printing, both technically and economically. website Circularise is a digital product passports and mass balance bookkeeping software provider founded in The Netherlands in 2016. Circularise's software system helps suppliers in chemicals, plastics, battery materials, metals, and other industries to trace materials and share their environmental footprint without risking their sensitive data. By extension, it helps brands to get visibility into their own Scope 3 emissions and other metrics, which is aligned with the regulatory push around Digital Product Passports, the SEC's proposed climate risk disclosure rules, and the Corporate Sustainability Reporting Directive. For access to updates about Circularise, subscribe to notifications from LinkedIn: https://www.linkedin.com/company/circularise website Curreio is a Tokyo-based drug discovery company focused on next generation drug design using a novel technology called cryo-electron microscopy. website Cyto-Facto is focusing on cell and gene therapy, engaged in contract manufacturing of cell products under facilities and systems that meet international standards. website Everactive combines battery-free sensors and cloud analytics to deliver end-to-end Industrial IoT solutions. The company's groundbreaking low-power semiconductor and networking technology is the foundation for self-powered, always-on wireless sensors. Ruggedized for harsh industrial settings, Everactive devices continuously stream asset health data through physical obstacles and interference at reliably long-range. Operating indefinitely off low levels of harvested energy, Everactive's technology delivers the most scalable and cost-effective digital transformation solutions. The company's first products are designed to monitor steam systems and a range of rotating equipment, such as motors, pumps, fans, and compressors. Everactive is headquartered in Silicon Valley, with design centers in Ann Arbor, MI and Charlottesville, VA. website Feldan Therapeutics is a preclinical biotechnology company developing leading-edge treatments based on a unique intracellular delivery technology; the Feldan Shuttle. Through its safety, ease of use and broad applicability the Feldan Shuttle gives access to a wide range of intracellular targets and therefore has the potential to bring a whole new class of therapies to the clinic. website Glycomine is developing orphan drugs for serious rare disorders that lack a functional sugar chain of glycoprotein for which no other therapeutic options exist.? The lead program is a mannose-1-phosphate replacement therapy in development to treat PMM2-CDG, a severe genetic disorder. website Hazel Technologies is a USDA-funded startup company that develops new technologies to extend the quality shelf life of fresh produce. Founded in 2015, Hazel Tech® works with over 100 of the largest fresh produce packers, shippers, and retailers in the US, Canada, and Latin America. For more information, visit www.hazeltechnologies.com. website HistoWiz mission is to fight cancer cooperatively instead of individually by connecting scientists, clinicians and patients for online collaboration. Previously, there was no large annotated Whole Slide Imaging (WSI) repository for histopathology data, making collaboration difficult and bioinformatics-driven discovery impossible. HistoWiz initiated the effort to break down data silos by digitizing histology slides from different academic institutes and pharmas in 2013. website Integral Geometry Science develops and sells various measurement systems based on the world's first theory of reverse analysis of electromagnetic fields and the theory of reverse analysis of scattered fields. Integral Geometry Science has succeeded in deriving analytical solutions for unsolved problems in applied mathematical history such as the "inverse problem of scattering" and several other inverse problems. The company's sales profile includes the tunnel performance inspection radar of the Kanto area for a railway company and the sale of an electric current path imaging system that can be used to non-destructively measure the electric current path of lithium ion secondary battery. The company's future plans include product development with respect to three fields, i.e., battery (current path imaging system), breast cancer (breast cancer screening system) and security (super-security gate). website Minimally invasive implantable device that treats patients experiencing moderate to severe CHF symptoms even after appropriate medical treatment website Ionomr Innovations is a clean technology company that develops and markets ion-exchange membrane and polymer solutions for fuel cell systems, hydrogen production, and CO2 conversion systems. Our highly differentiated products uniquely enable product developers and integrators around the globe to optimize their product performance, improve durability, eliminate toxic components, increase recyclability, and accelerate cost reduction activities. Ionomr Innovations leadership position in green hydrogen has been recognized by numerous third parties. Most recently, Ionomr Innovations was awarded with the2024 Governor General’s Innovation Award for our world-leading research on anion- and proton-exchange membranes that has progressed into the development and commercialization of our revolutionary polymer membrane materials. Additionally Ionomr Innovations has been recognized as the Future 50, by Corporate Knights in June 2023; as one of the Cleantech 100 by Cleantech Group in January 2022; Foresight 50 "most investable cleantech companies"; World Economic Forum's "Technology Pioneers", Inaugural member of AWS' Clean Energy Accelerator; Selection for Shell's "Game Changer" Program; 2020 Winner of the "Products and Markets" Award by top Fuel Cell Conference – Fcell, and 2019 Winner of Nouryon Imagine Chemistry program. website To reimagine and transform lymphatic and venous care through innovative people-centric technologies that improve lives and empower self care. website Novel medical device to improve the time to dialysis of a fistula as well as extending the life of the device. website Luca Science is a bippharmaceutical company developing functional mitochondria as therapeutic agents to treat damaged tissues and organs. website Early commercial stage company selling real time cell analyzer to pharma companies developing viral vaccines and gene therapies website Moment Energy provides clean, affordable, and reliable battery energy storage systems (BESS) by repurposing retired electric vehicle batteries. website Multus creates the key ingredient, the growth media, for the affordable scale-up of cellular agriculture website NFW is a platform for plastic-free performance materials spanning sheet goods, textiles, molded composites, and foams. NFW follows three Ground Rules in everything they develop: start well, stay clean, end well. The multi-material platform serves a wide range of industries—from fashion and footwear to automotive and upholstery. NFW technology embeds into existing supply chains, enabling the world’s most iconic brands to design and scale products with high-performance, naturally circular materials. NFW makes global brands more sustainable, empowering them to create without plastics. Alongside the boldest brands and visionary designers, NFW is pioneering a post-linear, post-oil economy. website Noctrix is is committed to developing the next generation of clinically validated, wearable therapeutics to address unmet needs for people with chronic medical conditions in a safe and effective manner. website PharmaIN Corporation, headquartered in Bothell, WA, (near Seattle) is developing superior drug therapies by using its "Protected Graft Co-polymer" (PGC) excipient and innovative peptide engineering technologies to enable effective and safe injectable peptide therapeutics. Besides peptides, PGC excipient can be beneficial to improve PK, bioavailability, stability and solubility of numerous proteins and some poorly soluble potent small molecules. PharmaIN works with partner companies to enable new, value-added drug therapies and improve "old" drugs using these platforms. website Plant Prefab Inc. designs and manufactures custom single and multifamily homes that are high-quality, sustainable, healthy, and durable. Its off-site production and patented building system significantly reduce construction time and cost, which enables affordable and sustainable home construction in the growing urban market. website Emerging medical device company with products to stop massive bleeding and treat other conditions website Plato unlocks the power of digital transformation and industrial automation through its integrated Tagless Activity Tracking platform. Our Deep Fusion perception technology tracks activity patterns of people, equipment, and assets in industrial operations and across logistics, warehousing, and manufacturing sites. The combination of frictionless location/activity data and our analytics layer provides actionable KPIs for productivity, safety, and to drive automation in physical operations. website Pulmocide is a biopharmaceutical company focused on the development and commercialization of transformational therapies for patients with severe pulmonary diseases.The lead program is a novel inhaled azole therapy for patients at risk of developing serious complications associated with aspergillosis, a severe fungal infection. website Research and development various solutions against kidney diseases, improve QOL among patients suffering from kidney diseases, and contribute to society. website Remall is an enterprise specialized in the development of technology in plastic recycling and providing environmentally friendly recycled plastic solution. The products mainly contain R-PP, R-PE, R-PS and R-ABS, which are successfully applied in toys, textiles, automobiles, packaging, daily use industries and so on. website Driving better health outcomes through better transportation. website SetPoint Medical is pioneering bioelectronic medicine to offer patients and providers a potentially safe and cost-effective approach for treatment of chronic autoimmune diseases. website SolidBlock transforms illiquid assets into tradable financial products, which are easy to buy and sell, collateralize for securing loans, and combine into structured products (like index funds). They were responsible for the world's first real estate tokenization back in 2018 and continue to use blockchain technology to redefine real assets. website Super is a San Francisco-based insurtech company. Powered by a proprietary data platform and backed by leading investors, Super offers subscription-based care for your home. Partnering with the best local servicers to deliver quick and effective home repair and maintenance at a predictable cost, Super's vision is to make caring for a home carefree. Visit www.hellosuper.com for more information. website Swing Therapeutics was founded in 2019 with the goal of developing digital treatments and services in disease areas where patients are not well-served, and where digital interventions may be effective. Its focus is on tackling autoimmune conditions and chronic overlapping pain conditions (COPCs) like fibromyalgia where central pain sensitization is a significant factor. The company is investing in research to support the development of prescription-based digital therapies and services. Swing Therapeutics received FDA Breakthrough Device Designation for its digital therapy for fibromyalgia management. Its near-term goal is to validate its digital therapy and bring it to market as an FDA-cleared, prescription digital therapeutic. website CDMO developing novel approaches to make synthetic DNA for gene therapies, vaccines and gene editing website TOOLBX is the leading construction materials marketplace that connects contractors, suppliers and logistics providers all on one platform. website Topsound is dedicated to advancing acoustic detection and monitoring technology in the battery sector. Over the years, it has immersed itself in technology, consistently innovating, and introducing a range of groundbreaking products tailored for diverse scenarios. website Trevi’s FO process is a disruptive technology which can help meet the world’s rapidly increasing demand for clean water using a small fraction of the energy required by state-of-the-art desalination processes. Trevi Systems, Inc. is innovating solutions that will enable people to have access to potable water regardless of geographic or socioeconomic barriers. website UltraSense has created the world's smallest ultrasound sensor that enables a touch user interface that differentiates products by removing mechanical buttons and enables new applications using a patented 3D ultrasound technology. website UV Angel was founded in 2014 with a mission to create cleaner and safer environments for people around the world through the development of intelligent disinfection technology. With a team of leading healthcare and science experts, the company uses years of experience to advance Ultraviolet Germicidal Irradiation (UVGI) Technology and Connected Digital IoT platforms. Automated and proven safe for occupied spaces, UV Angel leverages their platform-based technology to clean the air we breathe and surfaces we touch to help make the environments around us safer by killing viruses, bacteria, and fungi. UV Angel’s technology is complemented by a data analytics platform that delivers critical insights and strategic advantages to leaders in healthcare, food service, retail, corporate, education, and many more industries. website VitalConnect is a medical device and healthcare solutions company applying advanced biosensor technology and surrounding data management systems to deliver an innovative platform that is accretive to decision-making paradigms of physicians and other health care professionals. VitalConnect's FDA-cleared and CE -marked VitalPatch biosensing platform is available for use in hospitals, homes, research facilities, doctor's offices, and other care facilities. website Zaptic provides a connected worker platform for job instruction and collaboration for frontline teams, and a no-code toolkit designed to accelerate digital transformation of daily operations. Our mission is to improve the lives of frontline workers, by supporting safety, autonomy, productivity, and continuous learning in frontline jobs. Using Zaptic, global manufacturing and service organizations are able to not only unlock measurable improvements in productivity, quality and safety, but also enable a smooth transfer of knowledge between the retiring and new generation of workers to improve market resiliency. website At ZeroKey we have one mission; to drive optimization through digital transformation. Our world is inherently analog, rendering most "things" invisible to the digital domain. ZeroKey is changing that, one factory, warehouse, and facility at a time. Through our patented and breakthrough IIoT localization technology, Smart Space, ZeroKey is digitizing things that have never been digitized before. Driven by Smart Space's millimetre-level 3D digitization accuracy, we're bringing real-world workflows and processes into the digital realm like never before to power previously impossible digital solutions that redefine state-of-the-art. website Our Team USA Takashi Morishita, Ph.D. General Manager (Menlo Park) Takashi Morishita serves as General Manager of Asahi Kasei Corporate VC since 2008. While managing CVC, he has been active as a board member and board observer of portfolio company, he was involved in investment of more than 30 start-ups and lead acquisition of portfolio company. He has over 25 years of experience in open innovation, global partnership and strategic alliances mainly with high tech start-ups in US and Europe. He received his Ph.D, MS and BS in Chemical Engineering from the Tokyo Institute of Technology. Steven Berger, Ph.D. Managing Director (Boston) Steven joined Asahi Kasei America in 2013. He brings to the company over 30 years of experience in innovation and entrepreneurship and a strong record of driving concepts from R&D to product release. Prior to his current position Steven was CEO of Crystal IS, a start-up company that developed UV LEDs for the sterilization market; the company was acquired by Asahi Kasei in 2011. Before that he was at FEI Company, a manufacturer of electron microscopes, where he held a variety of roles including COO and CTO. Prior to FEI, he was in the research division at AT&T's Bell Labs. He received his PhD. from Cambridge University. He has been awarded a dozen US patents and has over 60 publications. Howard Kim, M.D. Managing Director (Boston) Howard Kim joined Asahi Kasei America in 2016 and is based outside Boston, MA. He is a Managing Director, focusing on healthcare investments. Prior to joining Asahi Kasei, Howard worked at Advent International, a global private equity firm, and Hambrecht and Quist Capital Management, a healthcare investment firm. His operational experience includes working as Chief Medical Officer and Vice President of Business Development at a venture-backed medical device company. Howard received his BA from Harvard College and his MD from Tufts School of Medicine. Chris Greeno Investment Director (Boston) Chris joined the Asahi Kasei CVC team in 2020 and is focused on medtech, digital therapeutics, and biotech. Prior to AK, Chris worked in life sciences strategy consulting and biotech business development. Chris received his BA in biology and economics from Williams College and his MBA in healthcare management from The Wharton School. Jeff Chen Investment Director (Albany, NY) Jeff Chen joined Asahi Kasei Corporate VC in 2023. Prior to his current position, Jeff was VP of Product Management and Development at Crystal IS, a ventured-back semiconductor device company Asahi Kasei acquired in 2012. At Crystal IS, Jeff also held a variety of roles managing Product Management, R&D, Engineering, Operations, Quality, Safety and Purchasing. Jeff received his Ph.D. in electrical engineering from Stony Brook University and his MBA from Stern at New York University. John S. Crowley Senior Advisor (Portland, Maine) Throughout his 30-year career, John has passionately pursued identifying and commercializing technologies spanning the building eco-system. John has held several management positions in the building products and homebuilding industry, including Research and Development Manager at NVR Ryan Homes, Vice President of PHI Building Systems, and Vice President of R&D at Rollease Acmeda. He served on the research faculty at MIT as the Director of the MIT Innovative Housing Technology Program, a multi-national industry supported program focused on advanced materials and systems for residential and light commercial buildings. John has founded several building material and product companies integrating design, workflow, and material technology to improve the end-to-end production process, customer experience and finished products. He is a board member of Plant Prefab, Toolbx and Skipp Technologies working with stakeholders to provide healthy, low impact, attainable housing solutions. He earned a master’s degree in architecture, planning & building technology from MIT. He has authored numerous publications and patents. Ryoichi Takashima Manager (Menlo Park) Ryoichi Takashima is focusing on IoT technology and creating new business. Before joining the CVC team, he worked as a ASIC designer in Asahi Kasei Microdevices Corporation (AKM) and developed sensor devices to achieve customer solutions incorporating AKM's software technology. He graduated Osaka University with a master's degree of science. Yo Nakayama Manager (Menlo Park) Yo Nakayama joined CVC team in 2022 and is in charge of the investment strategy and execution. Prior to CVC team, he worked for 15 years as a legal staff in steel manufacturing company and Asahi Kasei, facilitating business development through contract review, litigation management and compliance activities. He received the degree of Bachelor of Arts in faculty of letters from the University of Tokyo. Ken Kitamura Manager (Menlo Park) Ken Kitamura joined Asahi Kasei Corporate VC in 2024. Prior to his current role, Ken worked as a senior innovation architect driving the acceleration of multiple new business creation projects in a variety of fields including hydrogen, battery, and semiconductors at Asahi Kasei. Ken also worked at Crystal IS, a venture-backed semiconductor device company Asahi Kasei acquired in 2012. At Crystal IS, he managed product development projects of Japan and US teams. Ken holds a master’s degree in chemistry from Hokkaido University and an MBA from NUCB business school. Xinran Tao Manager (Boston) Xinran Tao is based in Boston, focusing on healthcare investment. Prior to joining the CVC team, she worked at Asahi Kasei Pharma Corporation, in charge of the in vitro diagnostics (IVD) business, and experienced roles in strategy, clinical trials, regulation, marketing, and medical affairs. She holds a master’s degree in bioengineering from the Tokyo Institute of Technology. Masatoshi Sakuma Principal, Homes Ventures (Menlo Park) Masatoshi is focusing on Construction & Real Estate. Before joining the CVC, he worked as a production engineer both in JFE steel and Asahi Kasei for 13 years. He has a Master's degree in Mechanical Engineering from Keio University in Japan. Shinichi Arita Manager (Menlo Park) Shinichi Arita creates new business opportunities in semiconductor and electronics devices sector for collaboration with AK business units. Before joining the CVC team, he worked for circuit design, software development of voice DSP, customer/FAE support, product planning and marketing in Asahi Kasei Microdevices(AKM) throughout his 15 years carrier. He also engaged to PMI work in France when AKM acquired a french startup. He received master of electronics from Hiroshima University and MBA from Waseda University. Dice Hotta Manager (Menlo Park) Daisuke Hotta is currently concentrating on Climate Tech as an investment field and is actively seeking new business ventures in the areas of Materials and Sustainability in collaboration with Asahi Kasei's business units and R&D department. Prior to his role in the CVC team, he spent five years in R&D where he was involved in the full spectrum of activities from research to pre-sales for a new membrane technology applicable to the food and pharmaceutical industries. He has filed over ten global patents and possesses extensive experience in research, development, scale-up, factory design, quality control, quality assurance, intellectual property strategy, and marketing. He later joined a strategic team for six months to consider a new business. Before his tenure at Asahi Kasei, he founded a marketing company during his university years. He holds a Master of Science degree in Macromolecular Science from Osaka University. Naoki Isobe Manager (Menlo Park) Naoki Isobe is focusing on battery related technologies and aims to co-create new businesses. Prior to coming to CVC, he was involved in semiconductor product planning and customer support at Asahi Kasei Microdevices(AKM) for twelve years. He holds a Master's degree in Electronic Engineering from the Osaka University. Europe Michinori Muraoka Manager (Düsseldorf) Michinori Muraoka is exploring new business opportunities in material and sustainability sector in collaboration with AK business units. Before joining the CVC team, He worked in Asahi Kasei's membrane division in various industrial fields and spent 5 years in India as country manager for business development of membrane technology in water sector. He received Bachelor of Business Administration from Hokkaido University and MBA from Kobe University. Tomo Ishikawa Senior Manager, Business Development, Green Solution Project (Düsseldorf) Based in Düsseldorf, Tomo Ishikawa specializes in identifying investment opportunities within the Hydrogen sector. Also, he oversees the business development of electrolyzers for hydrogen production in EU region. Previously, he was an integral part of the CVC team from 2015 to 2019, participating in numerous investment activities. In addition to his experience in CVC team, he had M&A experiences in Corporate Strategy Department, and had valuable experience as a brand manager in consumer brand marketing. China Yiqing Tao Investment director of CVC China (Shanghai,PRC) Yiqing Tao is based in Shanghai. She is in charge of all the CVC China activities including investment strategy, execution of both direct investment and VC fund investments and business collaborations with Asahi Kasei business units. Prior to Asahi Kasei, Yiqing worked in venture capital and private equity in China. Tao holds MSc degree in Finance from Cass Business School, London. Japan Masa Kaneta Senior Manager (Tokyo) Masa Kaneta is exploring new business opportunities in material and sustainability sector in collaboration with business units. Before joining the CVC team, he worked in Asahi Kasei Corporate Strategy as a manager of business developing and investment control and carbon neutral promotion project for 3 years. He held a variety of roles managing R&D, Engineering, Operations, Quality in Consumable BUS for 18 years. In addition, he had experienced marketing and researching new technologies in polymer engineering in Asahi Kasei America. Kohei Miyabe Manager (Tokyo) Kohei Miyabe is in charge of healthcare investment. He has expertise in pharmaceutical development, especially formulation science and CMC work. His dedicated research work led to one approved pharmaceutical in Japan and more than ten published patents. He also has research experience in nucleotide delivery for gene therapy. He has a master's degree of agricultural science from Nagoya University in Japan. Yoshiki Miyamoto Manager (Tokyo) Yoshiki Miyamoto is now focusing on IIoT and Sustainability. Before joining the CVC team, he worked on R&D in Asahi Kasei E-materials and Asahi Kasei for 10 years and he has been experienced in various applications for high performance polymers like epoxy-resin hardeners, photosensitive polymers, flexible display substrate, electrolyte membrane for fuel cell and drug delivery system. He has a Master of Engineering degree from Osaka University in Japan. Create the future, together. Phone: 650.853.1900 Fax:     650.853.8400 EMail:  akcvc@ak-america.com USA Menlo Park Office 4600 Bohannon Drive, Suite 220 Menlo Park, CA 94025 Boston Office 269 Mill Road Chelmsford, MA 01824 Germany Düsseldorf Office Fringsstraße 17, 40221 Düsseldorf China Shanghai Office 8/F,One ICC,Shanghai International Commerce Centre, No.999 Huaihai Zhong Road,Shanghai 200031 Our Featured Story - "Partnering up to create for tomorrow" June 25th 2020 Founded in 1922, Asahi Kasei is a diversified business based in Tokyo focused on three primary sectors: Material, Homes, and Health Care. Asahi Kasei Corporate Venture Capital was established in 2008 and is focused on investing in innovative global companies in areas of strategic importance to Asahi Kasei. Our primary mission is to create new long-term business opportunities for Asahi Kasei. Our team, based in Menlo Park, the Boston area, Düsseldorf and Shanghai, consists of senior professionals with backgrounds in R&D, start up operations and venture capital. Asahi Kasei invests across all stages. Our initial investment size can range from several hundred thousand dollars up to several million, depending on the opportunity. Given the right situation, Asahi Kasei can lead investments. © 2024 Asahi Kasei Asahi Kasei Corporation Our Products ∆jaja1730455501https://asahikaseiventures.com

ཁྱོད་རའི་ས་ཁོངས་ཞུན་དག་འབད་ག?

ཁྱོད༌ག༌ཅི༌འབདཝ༌སྨོ?